0000899243-22-018429.txt : 20220517 0000899243-22-018429.hdr.sgml : 20220517 20220517171935 ACCESSION NUMBER: 0000899243-22-018429 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220515 FILED AS OF DATE: 20220517 DATE AS OF CHANGE: 20220517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOHANTY ADITYA P. CENTRAL INDEX KEY: 0001629819 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39334 FILM NUMBER: 22935894 MAIL ADDRESS: STREET 1: 1010 ATLANTIC AVENUE, SUITE 102 CITY: ALAMEDA STATE: CA ZIP: 94501 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIORA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001580063 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 273950390 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4330 LA JOLLA VILLAGE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 855-293-2639 MAIL ADDRESS: STREET 1: 4330 LA JOLLA VILLAGE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: PROGENITY, INC. DATE OF NAME CHANGE: 20150617 FORMER COMPANY: FORMER CONFORMED NAME: ASCENDANT MDX, INC. DATE OF NAME CHANGE: 20130625 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-15 0 0001580063 BIORA THERAPEUTICS, INC. BIOR 0001629819 MOHANTY ADITYA P. C/O BIORA THERAPEUTICS, INC. 4330 LA JOLLA VILLAGE DRIVE, SUITE 200 SAN DIEGO CA 92122 1 1 0 0 Chief Executive Officer Common Stock 2022-05-15 4 A 0 1562500 0.00 A 2974929 D Stock Option (Right to Buy) 0.75 2022-05-15 4 A 0 2495425 0.00 A 2032-05-15 Common Stock 2495425 2495425 D Consists of 1,562,500 restricted stock units, 25% of which will vest on May 15, 2023, with the remaining shares vesting in equal semi-annual installments through May 15, 2026, subject to the Reporting Person's continued service to the Issuer. This option represents the right to purchase 2,495,425 shares of the Issuer's common stock, 25% of which will vest on May 15, 2023, with the remaining shares vesting in equal monthly installments through May 15, 2026, subject to the Reporting Person's continued service to the Issuer. /s/ Will Pridgen, Attorney-in-Fact for Aditya P. Mohanty 2022-05-17